Production (Stage)
Boundless Bio, Inc.
BOLD
$1.05
-$0.04-3.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 4.81% | 7.31% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.13% | -2.34% | |||
| Operating Income | 5.13% | 2.34% | |||
| Income Before Tax | 4.20% | 0.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.20% | 0.37% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.20% | 0.37% | |||
| EBIT | 5.13% | 2.34% | |||
| EBITDA | 5.33% | 2.55% | |||
| EPS Basic | 4.27% | 0.50% | |||
| Normalized Basic EPS | 4.27% | 0.52% | |||
| EPS Diluted | 4.27% | 0.50% | |||
| Normalized Diluted EPS | 4.27% | 0.52% | |||
| Average Basic Shares Outstanding | 0.07% | 0.13% | |||
| Average Diluted Shares Outstanding | 0.07% | 0.13% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||